Hitzler, J., Alonzo, T., Gerbing, R., Beckman, A., Hirsch, B., Raimondi, S., Chisholm, K., Viola, S., Brodersen, L., Loken, M., Tong, S., Druley, T., O’Brien, M., Hijiya, N., Heerema-McKenney, A., Wang, Y.-C., Shore, R., Taub, J., Gamis, A., … Berman, J. N. (2021). High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial. Blood, 138(23), 2337–2346. https://doi.org/10.1182/blood.2021012206